These neuropsychiatric morbidities are quite significant, with cognitive impairment and depression constituting two of the strongest determinants of PD quality of life [ 2 ].
← all excerpts
The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.
1
—
—